VenatoRx Pharmaceuticals, Inc. SBIR Phase II Award, July 2016
A SBIR Phase II contract was awarded to VenatoRx Pharmaceuticals in July, 2016 for $3,462,890.0 USD from the U.S. Department of Health & Human Services.
Name
# Contributions
Last Contribution
Find more entities like VenatoRx Pharmaceuticals, Inc. SBIR Phase II Award, July 2016
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.